Santhera Publishes Annual Report 2022 - Marketscreener.com
| SPHDF Stock | USD 9.42 0.00 0.00% |
Roughly 62% of Santhera Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Santhera Pharmaceuticals Holding pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Santhera Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Santhera Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Santhera Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Santhera daily returns and investor perception about the current price of Santhera Pharmaceuticals Holding as well as its diversification or hedging effects on your existing portfolios.
Santhera |
Santhera Publishes Annual Report 2022 Marketscreener.com
Read at news.google.com
 |
Santhera Pharmaceuticals Fundamental Analysis
We analyze Santhera Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Santhera Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Santhera Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Santhera Pharmaceuticals is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Santhera Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Santhera Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Santhera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Santhera Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Santhera Pharmaceuticals Related Equities
| ANAB | AnaptysBio | 6.50 | ||||
| DSGN | Design Therapeutics | 6.37 | ||||
| LEXX | Lexaria Bioscience | 2.06 | ||||
| ACHL | Achilles Therapeutics | 0.88 | ||||
| IVA | Inventiva | 0.46 | ||||
| IDYA | Ideaya Biosciences | 0.04 | ||||
| KROS | Keros Therapeutics | 0.18 | ||||
| GNFT | Genfit | 1.64 | ||||
| GHRS | GH Research | 2.11 | ||||
| ZVSA | ZyVersa Therapeutics | 5.41 | ||||
| BDRX | Biodexa Pharmaceticals | 5.45 | ||||
| MGTX | MeiraGTx Holdings | 5.77 |
Complementary Tools for Santhera Pink Sheet analysis
When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |